Ayala Pharmaceuticals Inc...

NASDAQ: AYLA · Real-Time Price · USD
0.53
-0.00 (-0.73%)
At close: Jan 18, 2023, 9:56 PM

Ayala Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
692K n/a
Cost of Revenue
602K 3.51M
Gross Profit
90K -3.51M
Operating Income
-37.5M -41.03M
Interest Income
n/a n/a
Pretax Income
-37.43M -39.48M
Net Income
-38.01M -38.7M
Selling & General & Admin
9.74M 9.28M
Research & Development
27.85M 29.94M
Other Expenses
n/a n/a
Operating Expenses
37.59M 39.22M
Interest Expense
-74K -1.55M
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
38.2M 42.72M
Income Tax Expense
584K -776K
Shares Outstanding (Basic)
15.45M 9.86M
Shares Outstanding (Diluted)
15.45M 9.86M
EPS (Basic)
-2.46 -3.92
EPS (Diluted)
-2.46 -3.92
EBITDA
-37.5M -40.86M
EBIT
-37.5M -41.03M
Depreciation & Amortization
162K 168K